DNX Biopharmaceuticals
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
(Cancelled)
1
INVESTORS
Description
Owner and operator of a biopharmaceutical company intended to develop long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company's biopharmaceutical services focus on development of new therapeutic proteins utilizing a half-life extension platform that produces therapeutic proteins and biological drugs to treat auto-inflammatory diseases, enabling medical researchers to facilitate treatment of rheumatoid arthritis and other related diseases, while off-setting the development cost through therapeutic proteins and biological drugs.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 19800 MacArthur Boulevard
- Suite 300
- Irvine, CA 92612
- United States
+1 (949) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore DNX Biopharmaceuticals’s full profile, request a free trial.
DNX Biopharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 01-Jul-2016 | Cancelled | Startup | |||
| 1. Accelerator/Incubator | 14-May-2016 | Completed | Startup |
DNX Biopharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| EvoNexus | Accelerator/Incubator | 000 0000 | 000000 0 |
DNX Biopharmaceuticals Executive Team (5)
DNX Biopharmaceuticals Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Howard Levine Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
| John Caputo | DNX Biopharmaceuticals | Co-Founder & Board Member | 000 0000 | |
| Rajiv Datar Ph.D | DNX Biopharmaceuticals | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 | |
| Thomas Zindrick JD | DNX Biopharmaceuticals | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 4 of 5 board members. Get the full list »